Feil Family Brain & Mind Research Institute
Found 577 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is K  [Clear All Filters]
2018
Kocsik AS, Klein DE, Liedke M, Kaunzner UW, Nealon NM, Gauthier SA, Vartanian T, Perumal JS.  2018.  Induction of disease remission with one cycle of alemtuzumab in relapsing-remitting MS.. J Neurol. 265(5):1226-1229.
Kocsik AS, Klein DE, Liedke M, Kaunzner UW, Nealon NM, Gauthier SA, Vartanian T, Perumal JS.  2018.  Induction of disease remission with one cycle of alemtuzumab in relapsing-remitting MS.. J Neurol. 265(5):1226-1229.
Parikh NS, Merkler AE, Kummer BR, Kamel H.  2018.  Ischemic Stroke After Emergency Department Discharge for Symptoms of Transient Neurological Attack.. Neurohospitalist. 8(3):135-140.
Parikh NS, Merkler AE, Kummer BR, Kamel H.  2018.  Ischemic Stroke After Emergency Department Discharge for Symptoms of Transient Neurological Attack.. Neurohospitalist. 8(3):135-140.
Orr AG, Lo I, Schumacher H, Ho K, Gill M, Guo W, Kim DH, Knox A, Saito T, Saido TC et al..  2018.  Istradefylline reduces memory deficits in aging mice with amyloid pathology.. Neurobiol Dis. 110:29-36.
Orr AG, Lo I, Schumacher H, Ho K, Gill M, Guo W, Kim DH, Knox A, Saito T, Saido TC et al..  2018.  Istradefylline reduces memory deficits in aging mice with amyloid pathology.. Neurobiol Dis. 110:29-36.
Orr AG, Lo I, Schumacher H, Ho K, Gill M, Guo W, Kim DH, Knox A, Saito T, Saido TC et al..  2018.  Istradefylline reduces memory deficits in aging mice with amyloid pathology.. Neurobiol Dis. 110:29-36.
Orr AG, Lo I, Schumacher H, Ho K, Gill M, Guo W, Kim DH, Knox A, Saito T, Saido TC et al..  2018.  Istradefylline reduces memory deficits in aging mice with amyloid pathology.. Neurobiol Dis. 110:29-36.
Merkler AE, Parikh NS, Kamel H.  2018.  Jump Starting Your Clinical Research Career Using Administrative Data Sets for Stroke Research.. Stroke. 49(10):e303-e305.
Jain D, M Puno R, Meydan C, Lailler N, Mason CE, Lima CD, Anderson KV, Keeney S.  2018.  ketu mutant mice uncover an essential meiotic function for the ancient RNA helicase YTHDC2.. Elife. 7
Morris NA, May TL, Motta M, Agarwal S, Kamel H.  2018.  Long-term risk of seizures among cardiac arrest survivors.. Resuscitation. 129:94-96.
Guiberson NGuy Lewis, Pineda A, Abramov D, Kharel P, Carnazza KE, Wragg RT, Dittman JS, Burré J.  2018.  Mechanism-based rescue of Munc18-1 dysfunction in varied encephalopathies by chemical chaperones.. Nat Commun. 9(1):3986.
Kamel H, Chung CD, Kone GJ, Gupta A, Morris NA, Fink ME, Navi BB.  2018.  Medical Specialties of Clinicians Providing Mechanical Thrombectomy to Patients With Acute Ischemic Stroke in the United States.. JAMA Neurol.
Kamel H, Chung CD, Kone GJ, Gupta A, Morris NA, Fink ME, Navi BB.  2018.  Medical Specialties of Clinicians Providing Mechanical Thrombectomy to Patients With Acute Ischemic Stroke in the United States.. JAMA Neurol.
Imam H, Khan M, Gokhale NS, McIntyre ABR, Kim G-W, Jang JYoung, Kim S-J, Mason CE, Horner SM, Siddiqui A.  2018.  -methyladenosine modification of hepatitis B virus RNA differentially regulates the viral life cycle.. Proc Natl Acad Sci U S A.
Imam H, Khan M, Gokhale NS, McIntyre ABR, Kim G-W, Jang JYoung, Kim S-J, Mason CE, Horner SM, Siddiqui A.  2018.  -methyladenosine modification of hepatitis B virus RNA differentially regulates the viral life cycle.. Proc Natl Acad Sci U S A.
Imam H, Khan M, Gokhale NS, McIntyre ABR, Kim G-W, Jang JYoung, Kim S-J, Mason CE, Horner SM, Siddiqui A.  2018.  -methyladenosine modification of hepatitis B virus RNA differentially regulates the viral life cycle.. Proc Natl Acad Sci U S A.
Liberman AL, Gialdini G, Bakradze E, Chatterjee A, Kamel H, Merkler AE.  2018.  Misdiagnosis of Cerebral Vein Thrombosis in the Emergency Department.. Stroke.
Parikh NS, Chatterjee A, Díaz I, Pandya A, Merkler AE, Gialdini G, Kummer BR, Mir SA, Lerario MP, Fink ME et al..  2018.  Modeling the Impact of Interhospital Transfer Network Design on Stroke Outcomes in a Large City.. Stroke. 49(2):370-376.
Parikh NS, Chatterjee A, Díaz I, Pandya A, Merkler AE, Gialdini G, Kummer BR, Mir SA, Lerario MP, Fink ME et al..  2018.  Modeling the Impact of Interhospital Transfer Network Design on Stroke Outcomes in a Large City.. Stroke. 49(2):370-376.
Palomo GM, Granatiero V, Kawamata H, Konrad C, Kim M, Arreguin AJ, Zhao D, Milner TA, Manfredi G.  2018.  Parkin is a disease modifier in the mutant SOD1 mouse model of ALS.. EMBO Mol Med.
Palomo GM, Granatiero V, Kawamata H, Konrad C, Kim M, Arreguin AJ, Zhao D, Milner TA, Manfredi G.  2018.  Parkin is a disease modifier in the mutant SOD1 mouse model of ALS.. EMBO Mol Med.
Palomo GM, Granatiero V, Kawamata H, Konrad C, Kim M, Arreguin AJ, Zhao D, Milner TA, Manfredi G.  2018.  Parkin is a disease modifier in the mutant SOD1 mouse model of ALS.. EMBO Mol Med.
Merkler AE, Gialdini G, Lerario MP, Parikh NS, Morris NA, Kummer B, Dunn L, Reznik ME, Murthy SB, Navi BB et al..  2018.  Population-Based Assessment of the Long-Term Risk of Seizures in Survivors of Stroke.. Stroke.
Merkler AE, Gialdini G, Lerario MP, Parikh NS, Morris NA, Kummer B, Dunn L, Reznik ME, Murthy SB, Navi BB et al..  2018.  Population-Based Assessment of the Long-Term Risk of Seizures in Survivors of Stroke.. Stroke.